MG-132
Cat.No:IM0310 Solarbio
CAS:133407-82-6
Molecular Formula:C26H41N3O5
Molecular Weight:475.62
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Metabolic Enzyme & Protease >
MG-132CAS:133407-82-6
Molecular Formula:C26H41N3O5
Molecular Weight:475.62
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
CAS | 133407-82-6 |
Name | MG-132 |
Molecular Formula | C26H41N3O5 |
Molecular Weight | 475.62 |
Solubility | Soluble in DMSO ≥5mg/mL |
Purity | ≥98% |
Appearance | White to yellow Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD00674886 |
SMILES | O=C(OCC1=CC=CC=C1)N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C([H])=O)CC(C)C)=O)=O)CC(C)C |
InChIKey | TZYWCYJVHRLUCT-VABKMULXSA-N |
InChI | InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1 |
PubChem CID | 462382 |
Target Point | Proteasome;Autophagy |
Passage | Autophagy;Metabolic Enzyme&Protease |
Background | MG-132 is a novel, specific, potent, reversible and cell-permeable proteasome inhibitor, and also inhibits calpain. It is also a polypeptide aldehyde, a potent autophagy activator. |
Biological Activity | MG-132是一种有效, 可逆, 能渗透细胞的 20S蛋白酶体抑制剂。它抑制蛋白酶体胰凝乳蛋白酶样肽酶活性的 IC50值为 24.2 nM[1]。 |
IC50 | IC50: 24.2nM (chymotrypsin-like activity) [1] |
Data Literature Source | [1]. Braun HA, et al. Tripeptide mimetics inhibit the 20 S proteasome by covalent bonding to the active threonines. J Biol Chem. 2005 Aug 5; 280 (31) :28394-401. [2]. Han YH, et al. The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH. Oncol Rep. 2009 Jul; 22 (1) :215-21. [3]. Fan WH, et al. Proteasome inhibitor MG-132 induces C6 glioma cell apoptosis via oxidative stress. Acta Pharmacol Sin. 2011 May; 32 (5) :619-25. [4]. Matsumoto Y, et al. Enhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating theproteasome inhibitor MG132. Cancer Sci. 2016 Jun; 107 (6) :773-81. [5]. Chen B, et al. MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals. Acta Biochim Biophys Sin (Shanghai) . 2010 Apr; 42 (4) :253-8. |
Unit | Bottle |
Specification | 5mg 10mM*1mL in DMSO 10mg 25mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer
Click to check >>Author:Song Runjie, Guo Peilan, Ren Xin, Zhou Lijun, Li Peng, Rahman Nafis A, Wo?czyński S?awomir, Li Xiru, Zhang Yanjun, Liu Mei, Liu Jiali, Li Xiangdong
IF:37.3000
Publish_to:Molecular Cancer
PMID:37408008
Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2
Click to check >>Author:Zhen Wu; Zhijie Cao; Han Yao; Xiaojun Yan; Wenbin
IF:8.8000
Publish_to:Cell Reports
PMID:37379210